Purple Biotech Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Purple Biotech Ltd., a foreign private issuer, covers the month of February 2025. The primary purpose of this report is to announce the convening of the Company's Annual General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a corporate governance notice rather than a financial results report.
Material Changes
No material financial changes or operational updates versus prior periods are disclosed in this specific filing.
Guidance, Outlook, and Corporate Actions
- Annual General Meeting: Scheduled for Tuesday, April 15, 2025, at 4:30 p.m. Israel time.
- Location: Company offices at 4 Oppenheimer Street, Science Park, Rehovot, Israel.
- Voting Materials: The Notice of Annual General Meeting, Proxy Statement, and Voting Slip for ordinary shares are attached as Exhibit 99.1.
- ADS Holders: BNY Mellon, the Depositary, will distribute a Voting Instruction Form for American Depositary Shares (ADSs), attached as Exhibit 99.2.
- Registration Statements: The report is incorporated by reference into multiple prior Registration Statements (Forms S-8, F-3, and F-1) filed between 2016 and 2024.
Key Facts for Investor Verification
- Verify the date and time of the Annual General Meeting (April 15, 2025).
- Confirm receipt of voting materials (Exhibit 99.1 for ordinary shares; Exhibit 99.2 for ADS holders).
- Note that this filing contains no financial performance data; refer to the most recent Form 20-F for financial metrics.